| Active Ingredient | FLECAINIDE |
| Therapeutic Class | ANTIARRHYTHMIC AGENTS |
| Indications | Supraventricular arrhythmias, ventricular arrhythmias. |
| Caution | Dizziness, visual disturbances, fatigue, and lightheadedness. |
| Dose Range | Adult: Supraventricular arrhythmias: Initially 50 mg twice daily , increased if necessary up to 300 mg daily. Ventricular arrhythmias: Initially 100 mg twice daily for 3-5 days, maximum 400 mg daily reserved for rapid control or in heavily built patien |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |